MDAS News 24.41 Medassets Inc (MDAS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medassets Inc (MDAS) 24.41 $MDAS

MedAssets to Report First Quarter 2014 Financial Results on Wednesday, April 30th After 4:00 p.m. ET
GlobeNewswire - Mon Apr 07, 1:33PM CDT
MedAssets, Inc. (Nasdaq:MDAS) today announced that it plans to release its financial results for the first quarter ended March 31, 2014 after 4:00 p.m. ET on Wednesday, April 30, 2014.

MedAssets Shares Up 12.7% Since SmarTrend's Buy Recommendation (MDAS)
Comtex SmarTrend(R) - Fri Apr 04, 10:03AM CDT
SmarTrend identified an Uptrend for MedAssets (NASDAQ:MDAS) on January 22nd, 2014 at $22.19. In approximately 2 months, MedAssets has returned 12.69% as of today's recent price of $25.00.

JOHN A. BARDIS, President and CEO, MedAssets, Inc. SEMDA 2014 Conference Gala Keynote Speaker
PR Newswire - Wed Apr 02, 3:35PM CDT
John A. Bardis, President and CEO of MedAssets, Inc., will headline the SEMDA 2014 Conference Thriving During Healthcare Reform as the Gala speaker. The SEMDA 2014 Conference is May 7-8 at the Renaissance Atlanta Waverly Hotel & Convention Center. Mr. Bardis founded MedAssets in June 1999 and has served as Chairman, President and Chief Executive Officer since its inception. With more than 30 years of experience in the healthcare industry, beginning with American Hospital Supply and Baxter International, he has held various senior management positions, including Vice President of the Baxter Operating Room Division and General Manager of the Eastern Zone.

MedAssets Announces Response to ICD-10 Transition Delay
GlobeNewswire - Mon Mar 31, 6:10PM CDT
MedAssets (Nasdaq:MDAS) announces its response to today's Congressional vote that delays the ICD-10 compliance date to October 1, 2015. The "doc fix" bill passed by the U.S. Senate averts a reduction in Medicare provider payments but included language that rolls back national adoption of new claim code sets.

Shares of MDAS Up 10.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 27, 5:22PM CDT
SmarTrend identified an Uptrend for MedAssets (NASDAQ:MDAS) on January 22nd, 2014 at $22.19. In approximately 2 months, MedAssets has returned 10.50% as of today's recent price of $24.52.

First Week of MDAS May 17th Options Trading
DividendChannel.com - Thu Mar 27, 12:07PM CDT
Investors in MedAssets Inc saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDAS options chain for the new May 17th contracts and identified one...

Baptist Health Care Engages MedAssets for Total Cost Management and Enhanced Operational Efficiency Across the Enterprise
GlobeNewswire - Tue Mar 25, 7:30AM CDT
MedAssets (Nasdaq:MDAS) today announced that Baptist Health Care (BHC), a four-hospital health system and member of the Mayo Clinic Care Network, has signed a multi-year agreement that replaces its incumbent vendor for a wide array of the company's total cost management and operational efficiency solutions. The Pensacola, Fla.-based health system will utilize the company's Strategic Sourcing, Operational Improvement, Clinical Resource Management, Procure-to-Pay solutions, as well as Cost Analytics and Operational Analytics tools. Plans call for multiple initiatives designed to reduce the organization's overall cost structure on a sustainable basis by identifying savings opportunities--both in price and utilization.

R. Halsey Wise Joins MedAssets Board of Directors
GlobeNewswire - Thu Mar 13, 11:00AM CDT
MedAssets, Inc. (Nasdaq:MDAS) is pleased to announce that R. Halsey Wise has joined the company's board of directors. Mr. Wise is the founder and chief executive officer of Lime Barrel Advisors, a private investment firm. In his new position with MedAssets, Mr. Wise will also be a member of the information technology and compensation committees of the board of directors.

MedAssets Has Returned 13.7% Since SmarTrend Recommendation (MDAS)
Comtex SmarTrend(R) - Thu Mar 13, 9:44AM CDT
SmarTrend identified an Uptrend for MedAssets (NASDAQ:MDAS) on January 22nd, 2014 at $22.19. In approximately 2 months, MedAssets has returned 13.74% as of today's recent price of $25.24.

MedAssets Beats on Q4 Earnings, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 9:45AM CST
Following the favorable earnings announcement, shares of MedAssets rose 10.8% till the last closing date

Downgrade Alert for MedAssets (MDAS)
Comtex SmarTrend(R) - Tue Mar 04, 7:57AM CST
MedAssets (NASDAQ:MDAS) was downgraded from Overweight to Equal Weight at First Analysis today. The stock closed yesterday at $23.94 on volume of 744,000 shares, above average daily volume of 652,000. MedAssets (NASDAQ:MDAS) has potential upside of 7.0% based on a current price of $23.94 and analysts' consensus price target of $25.62. The stock should find initial support at its 200-day moving average (MA) of $21.45 and further support at its 50-day MA of $21.12.

Latest National Sourcing Collaborative Program from MedAssets Delivers Participating Providers Substantial Savings in Lab Distribution
GlobeNewswire - Tue Mar 04, 7:31AM CST
MedAssets (Nasdaq:MDAS) today announced that its latest National Sourcing Collaborative event, a program designed to generate lowest market price points in products and services, will drive an estimated $5 million annually in added value in the laboratory distribution services category for participating MedAssets clients. A three-year contract for lab distribution was awarded for more than 100 MedAssets healthcare provider IDNs and hospitals, representing 25 percent of the annual MedAssets GPO spend in this category.

MedAssets to Present at Two Investment Conferences in March 2014
GlobeNewswire - Fri Feb 28, 1:00PM CST
MedAssets (Nasdaq:MDAS) today announced that it will participate in two investment conferences during the month of March.

13.9% Return Seen to Date on SmarTrend MedAssets Call (MDAS)
Comtex SmarTrend(R) - Fri Feb 28, 9:31AM CST
SmarTrend identified an Uptrend for MedAssets (NASDAQ:MDAS) on January 22nd, 2014 at $22.19. In approximately 1 month, MedAssets has returned 13.89% as of today's recent price of $25.27.

Nasdaq stocks posting largest percentage increases
AP - Thu Feb 27, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Why MedAssets (MDAS) Is Spiking Today
at The Street - Thu Feb 27, 2:05PM CST
MedAssets (MDAS) rises after the company, which provides clinical resource management and revenue cycle management solutions for the health-care industry, reported its fourth-quarter results and issued guidance for the fiscal year 2014. The company...

Why MedAssets, Inc. Shares Spiked Higher
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 27, 11:49AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of MedAssets , a cloud-based provider of...

MedAssets Announces Share Repurchase Plan
GlobeNewswire - Wed Feb 26, 3:09PM CST
MedAssets, Inc. (Nasdaq:MDAS) today announced that its Board of Directors has authorized the repurchase of up to $75 million of the company's common stock over the next twelve months. The share repurchase program is intended to be implemented through purchases made from time to time using a variety of methods, which may include open market purchases, accelerated share repurchases, 10b5-1 trading plans, privately negotiated transactions or block trades, or any combination of such methods, in accordance with applicable insider trading and other securities laws and regulations.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 133

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 91

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 68

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 44

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 110

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading

Top 5 Most Recently Viewed Articles

Epic Yoga Event by Real Essentials to Support Ovarian Cancer

Updated Category News Views 70

Real Essentials Teams Up for Ovarian Cancer Awareness To honor Ovarian Cancer Awareness Month, Real Essentials, a brand celebrated for its affordable yet high-quality apparel, partnered with Not These Ovaries, a nonprofit organization dedicated to ovarian cancer. Together, they created a unique yoga event that aimed to raise both awareness and funds for essential ovarian...

Continue Reading
MKDWELL Tech Inc. Posts H1 2024 Financial Results Drop

Updated Category News Views 115

MKDWELL Tech Inc. Financial Overview for 2024 MKDWELL Tech Inc. (NASDAQ: MKDW), a key player in the automotive electronics industry with operations in Mainland China and Taiwan, has provided an update on its financial status for the first half of the fiscal year. The latest results show a significant decline in revenue compared to the same period in the previous year....

Continue Reading
Northwest Pipe Company Strengthens Production with New Facility

Updated Category News Views 212

Northwest Pipe Company Enhances Production Capacity Northwest Pipe Company, renowned for its expertise in water-related infrastructure, has announced a significant upgrade to its production facilities. The company has recently inaugurated a new precast concrete pipe and manhole manufacturing plant aimed at addressing the rising demand in the region. With this strategic...

Continue Reading
Allient Inc. Posts Third Quarter Gains Driven by Initiatives

Updated Category News Views 99

Allient Inc. Announces Impressive Third Quarter Results Allient Inc. (NASDAQ: ALNT), a global leader in precision and specialty Motion, Controls and Power products, has announced significant financial results for its third quarter. Despite facing challenges in key industrial and vehicle markets, the company has demonstrated resilience through its operational improvements...

Continue Reading
Fulcrum Therapeutics Investor Event to Unveil PIONEER Findings

Updated Category News Views 191

Introduction to Fulcrum Therapeutics Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a pioneering biopharmaceutical company, is dedicated to enhancing the lives of individuals grappling with genetically defined rare diseases. Their primary focus is on developing innovative small molecules that target specific diseases at their root cause. This commitment drives their latest...

Continue Reading